Conversion of 99mtechnetium-pyrophosphate scintigraphy in a patient with hereditary ATTR amyloidosis: importance of repeat scanning. [PDF]
Eur Heart J Case Rep, 2020 Hussain M, Sperry BW, Hanna M, Jaber WA.
europepmc +1 more source
Treatment of transthyretin (TTR) amyloid cardiomyopathy with an antisense oligonucleotide inhibitor of TTR synthesis [PDF]
, 2015 Ackermann, Elizabeth J +2 more
core +1 more source
Carpal tunnel syndrome, spinal canal stenosis, cardiomyopathy, renal insufficiency, enteropathy, and diffuse myopathy as an expression of systemic ATTR amyloidosis - diagnostics and therapy. [PDF]
J Surg Case RepRadmer S, Andresen JR.
europepmc +1 more source
Correction to: Conventional heart failure therapy in cardiac ATTR amyloidosis. [PDF]
Eur Heart Jeuropepmc +1 more source
Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study [PDF]
core +1 more source
1) SiRNA Therapy for Hereditary ATTR Amyloidosis
Nihon Naika Gakkai ZasshiYoshiki Sekijima, Hiroaki Kitaoka
openaire +1 more source
Related searches:
Myelopathy in hereditary ATTR Val30Met amyloidosis patients
Amyloid, 2021Hereditary transthyretin (ATTRv) amyloidosis is caused by deposition of misfolded transthyretin protein, which aggregates in amyloid fibrils and disrupts several organs [1].
Gonçalo Videira +5 more
openaire +2 more sources
Targeted treatments of AL and ATTR amyloidosis
Heart Failure Reviews, 2021The therapeutic landscape for cardiac amyloidosis is rapidly evolving. In the last decade, our focus has shifted from dealing with the inevitable complications of continued extracellular infiltration of amyloid fibrils to earlier identification of these patients with prompt initiation of targeted therapy to prevent further deposition.
Pranav, Chandrashekar +2 more
openaire +2 more sources